Halia Therapeutics at ASH 2026
Dec 12–15, 2026 New Orleans, LA ~30k attendees Website
Halia Therapeutics at ASH 2026 in New Orleans: Booth 457.
| Organization | ASH 2026 Attendance |
|---|---|
Halia Therapeutics Lehi, UT | |
Clinical-stage company targeting the LRRK2, NEK7 and NLRP3 inflammation pathway; its NEK7 modulator HT-6184 is in Phase 2 for MDS. | Booth Exhibiting at Booth 457 Sat, Dec 1211:00am–5:00pmSun, Dec 1310:00am–5:00pmMon, Dec 1410:00am–2:00pm |
Instantly find 20 buyers from Halia Therapeutics
Get a list of who you should contact, their contact info, and what to say.
Totally free and instant, no sign up necessary!
Not affiliated with or endorsed by the American Society of Hematology (ASH). Submit a correction